COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,196 Articles (22,713 medRxiv, 8,483 bioRxiv)

Most recent first Previous |  Page 2964: Articles 29631-29640  | Next

Immuno-informatics Characterization SARS-CoV-2 Spike Glycoprotein for Prioritization of Epitope based Multivalent Peptide Vaccine
Ismail, S., Ahmad, S., Azam, S. S.
10.1101/2020.04.05.026005 — Posted: 2020-04-12
A Computational Approach to Design Potential siRNA Molecules as a Prospective Tool for Silencing Nucleocapsid Phosphoprotein and Surface Glycoprotein Gene of SARS-CoV-2
Chowdhury, U. F., Sharif Shohan, M. U., Hoque, K. I., Beg, M. A., Moni, M. A., Sharif Siam, M. K.
10.1101/2020.04.10.036335 — Posted: 2020-04-12
Mechanistic modeling of the SARS-CoV-2 disease map
Rian, K., Esteban-Medina, M., Hidalgo, M. R., Cubuk, C., Falco, M. M., Loucera, C., Gunyel, D., Ostaszewski, M., Pena-Chilet, M., Dopazo, J.
10.1101/2020.04.12.025577 — Posted: 2020-04-12
Sequence, infectivity and replication kinetics of SARS-CoV-2 isolated from COVID-19 patients in Canada
Banerjee, A., Nasir, J. A., Budylowski, P., Yip, L., Aftanas, P., Christie, N., Ghalami, A., Baid, K., Raphenya, A. R., Hirota, J. A., Miller, M. S., Ostrowski, M. A., Kozak, R. A., McArthur, A. G., Mossman, K., Mubareka, S.
10.1101/2020.04.11.037382 — Posted: 2020-04-12
Insights on early mutational events in SARS-CoV-2 virus reveal founder effects across geographical regions
Farkas, C., Fuentes-Villalobos, F., Garrido, J. L., Haigh, J. J., Barria, M. I.
10.1101/2020.04.09.034462 — Posted: 2020-04-12 Discussion: Onsite | Offsite
BIP4COVID19: Releasing impact metrics data for articles relevant to COVID-19
Vergoulis, T., Kanellos, I., Chatzopoulos, S., Pla Karidi, D., Dalamagas, T.
10.1101/2020.04.11.037093 — Posted: 2020-04-12
Scutellaria baicalensis extract and baicalein inhibit replication of SARS-CoV-2 and its 3C-like protease in vitro
Liu, H., Ye, F., Sun, Q., Liang, H., Li, C., Lu, R., Huang, B., Tan, W., Lai, L.
10.1101/2020.04.10.035824 — Posted: 2020-04-12 Discussion: Onsite | Offsite
Comparison of SARS-CoV-2 infections among 3 species of non-human primates
Lu, S., Zhao, Y., Yu, W., Yang, Y., Gao, J., Wang, J., Kuang, D., Yang, M., Yang, J., Ma, C., Xu, J., Li, H., Zhao, S., Li, J., Wang, H., Long, H., Zhou, J., Luo, F., Ding, K., Wu, D., Zhang, Y., Dong, Y., Liu, Y., Zheng, Y., Lin, X., Jiao, L., Zheng, H., Dai, Q., Sun, Q., Hu, Y., Ke, C., Liu, H., Peng, X.
10.1101/2020.04.08.031807 — Posted: 2020-04-12 Discussion: Onsite | Offsite
The SARS-CoV-2 receptor-binding domain elicits a potent neutralizing response without antibody-dependent enhancement
Quinlan, B. D., Mou, H., Zhang, L., Gao, Y., He, W., Ojha, A., Parcells, M. S., Luo, G., Li, W., Zhong, G., Choe, H., Farzan, M.
10.1101/2020.04.10.036418 — Posted: 2020-04-12 Discussion: Onsite
Analysis of Ten Microsecond simulation data of SARS-CoV-2 dimeric main protease
Parves, R., Riza, Y., Mahmud, S., Islam, R., Ahmed, S., Evy, B. A., Hasan, H., Halim, M. A.
10.1101/2020.04.10.036020 — Posted: 2020-04-12

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).